
New Research for Borderline Resectable Locally Advanced Pancreatic Cancer Patients
PLYMOUTH MEETING, PA — New research in the September 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic …
New Research for Borderline Resectable Locally Advanced Pancreatic Cancer Patients Read More